Condition: Peripheral T-Cell Lymphoma, Not Otherwise Specified · Angioimmunoblastic T-cell Lymphoma · Follicular T-Cell Lymphoma · Sponsor: Corvus Pharmaceuticals, Inc.
A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas (FHTCLs), or systemic anaplastic large-cell lymphoma (sALCL).
This description comes directly from the study's public registry record.
Study Director · 650-900-4520 · clinicaltrials@corvuspharma.com
Always discuss trial participation with your own doctor first.
| City of Hope National Medical Center | Duarte, California, United States | Recruiting |
| University of California, Irvine | Irvine, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine | Miami, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC | Chicago, Illinois, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University of Maryland Medical Center | Baltimore, Maryland, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Roger Cancer Center University of Michigan Health | Ann Arbor, Michigan, United States | Recruiting |
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06561048